China Pharmaceutical Trade: Hormones and their Medicaments
China Export: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone)
CN: Export: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) data was reported at 16.262 USD th in Feb 2018. This records a decrease from the previous number of 26.196 USD th for Jan 2018. CN: Export: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) data is updated monthly, averaging 25.191 USD th from Mar 2012 (Median) to Feb 2018, with 12 observations. The data reached an all-time high of 137.230 USD th in Jun 2016 and a record low of 12.179 USD th in Aug 2017. CN: Export: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 16.262 Feb 2018 | monthly | Mar 2012 - Feb 2018 |
View China's China Export: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) from Mar 2012 to Feb 2018 in the chart:
China Export: 7-Keto-Prasterone
CN: Export: 7-Keto-Prasterone data was reported at 7.463 USD th in Feb 2018. This records an increase from the previous number of 3.663 USD th for Jan 2018. CN: Export: 7-Keto-Prasterone data is updated monthly, averaging 9.445 USD th from Jan 2014 (Median) to Feb 2018, with 10 observations. The data reached an all-time high of 30.000 USD th in Jan 2014 and a record low of 0.740 USD th in Sep 2015. CN: Export: 7-Keto-Prasterone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 7.463 Feb 2018 | monthly | Jan 2014 - Feb 2018 |
View China's China Export: 7-Keto-Prasterone from Jan 2014 to Feb 2018 in the chart:
Export: Growth Hormone Derivatives & Structural Analogues
CN: Export: Growth Hormone Derivatives & Structural Analogues data was reported at 24.000 USD th in Mar 2018. This records an increase from the previous number of 1.811 USD th for Jan 2018. CN: Export: Growth Hormone Derivatives & Structural Analogues data is updated monthly, averaging 2.144 USD th from Feb 2014 (Median) to Mar 2018, with 28 observations. The data reached an all-time high of 94.198 USD th in Oct 2016 and a record low of 0.000 USD th in Sep 2016. CN: Export: Growth Hormone Derivatives & Structural Analogues data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 24.000 Mar 2018 | monthly | Feb 2014 - Mar 2018 |
View China's Export: Growth Hormone Derivatives & Structural Analogues from Feb 2014 to Mar 2018 in the chart:
China Export: Medicament Containing Corticosteroed Hormone
CN: Export: Medicament Containing Corticosteroed Hormone data was reported at 3,965.587 USD th in Mar 2018. This records an increase from the previous number of 2,230.137 USD th for Feb 2018. CN: Export: Medicament Containing Corticosteroed Hormone data is updated monthly, averaging 2,275.096 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 9,802.253 USD th in Aug 2015 and a record low of 468.819 USD th in Feb 2013. CN: Export: Medicament Containing Corticosteroed Hormone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 3,965.587 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Export: Medicament Containing Corticosteroed Hormone from Jan 2011 to Mar 2018 in the chart:
China Export: Mibolerone, Nandrolone, Norbolethone, Norclostebol
CN: Export: Mibolerone, Nandrolone, Norbolethone, Norclostebol data was reported at 2,579.249 USD th in Mar 2018. This records an increase from the previous number of 43.954 USD th for Feb 2018. CN: Export: Mibolerone, Nandrolone, Norbolethone, Norclostebol data is updated monthly, averaging 1,535.646 USD th from Jan 2011 (Median) to Mar 2018, with 72 observations. The data reached an all-time high of 6,663.900 USD th in Jun 2013 and a record low of 7.748 USD th in Sep 2017. CN: Export: Mibolerone, Nandrolone, Norbolethone, Norclostebol data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 2,579.249 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Export: Mibolerone, Nandrolone, Norbolethone, Norclostebol from Jan 2011 to Mar 2018 in the chart:
China Export: Other Medicament Containing Hormone or Product of Heading 2937
CN: Export: Other Medicament Containing Hormone or Product of Heading 2937 data was reported at 1,371.305 USD th in Mar 2018. This records a decrease from the previous number of 1,689.017 USD th for Feb 2018. CN: Export: Other Medicament Containing Hormone or Product of Heading 2937 data is updated monthly, averaging 1,922.303 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 3,957.088 USD th in Apr 2015 and a record low of 543.905 USD th in Sep 2017. CN: Export: Other Medicament Containing Hormone or Product of Heading 2937 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 1,371.305 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Export: Other Medicament Containing Hormone or Product of Heading 2937 from Jan 2011 to Mar 2018 in the chart:
China Export: Other Medicament Containing Recombinant Human Insulin (Excl Antibiotics)
CN: Export: Other Medicament Containing Recombinant Human Insulin (Excl Antibiotics) data was reported at 0.000 USD th in Dec 2017. This stayed constant from the previous number of 0.000 USD th for Nov 2017. CN: Export: Other Medicament Containing Recombinant Human Insulin (Excl Antibiotics) data is updated monthly, averaging 0.000 USD th from Mar 2012 (Median) to Dec 2017, with 19 observations. The data reached an all-time high of 13.000 USD th in Apr 2013 and a record low of 0.000 USD th in Dec 2017. CN: Export: Other Medicament Containing Recombinant Human Insulin (Excl Antibiotics) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Dec 2017 | monthly | Mar 2012 - Dec 2017 |
View China's China Export: Other Medicament Containing Recombinant Human Insulin (Excl Antibiotics) from Mar 2012 to Dec 2017 in the chart:
Export: Other Polypeptide Hormone, their Derivative & Structural Analogue
CN: Export: Other Polypeptide Hormone, their Derivative & Structural Analogue data was reported at 10,754.887 USD th in Mar 2018. This records an increase from the previous number of 5,349.551 USD th for Feb 2018. CN: Export: Other Polypeptide Hormone, their Derivative & Structural Analogue data is updated monthly, averaging 2,584.767 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 10,754.887 USD th in Mar 2018 and a record low of 421.703 USD th in Feb 2011. CN: Export: Other Polypeptide Hormone, their Derivative & Structural Analogue data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 10,754.887 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Export: Other Polypeptide Hormone, their Derivative & Structural Analogue from Jan 2011 to Mar 2018 in the chart:
Export: Other Somatotropin, its Derivative & Structural Analogue
CN: Export: Other Somatotropin, its Derivative & Structural Analogue data was reported at 14,889.879 USD th in Mar 2018. This records an increase from the previous number of 10,770.876 USD th for Feb 2018. CN: Export: Other Somatotropin, its Derivative & Structural Analogue data is updated monthly, averaging 6,185.312 USD th from Jan 2008 (Median) to Mar 2018, with 123 observations. The data reached an all-time high of 28,510.910 USD th in Dec 2017 and a record low of 1,821.776 USD th in May 2011. CN: Export: Other Somatotropin, its Derivative & Structural Analogue data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 14,889.879 Mar 2018 | monthly | Jan 2008 - Mar 2018 |
View China's Export: Other Somatotropin, its Derivative & Structural Analogue from Jan 2008 to Mar 2018 in the chart:
China Export: Single Preparation with Recombinant Human Insulin
CN: Export: Single Preparation with Recombinant Human Insulin data was reported at 149.709 USD th in Mar 2018. This records a decrease from the previous number of 178.148 USD th for Feb 2018. CN: Export: Single Preparation with Recombinant Human Insulin data is updated monthly, averaging 1,026.476 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 12,788.200 USD th in Dec 2014 and a record low of 0.000 USD th in Apr 2013. CN: Export: Single Preparation with Recombinant Human Insulin data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 149.709 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Export: Single Preparation with Recombinant Human Insulin from Jan 2011 to Mar 2018 in the chart:
Export: Single Preparation, Containing 1-testosterone or Testosterone
CN: Export: Single Preparation, Containing 1-testosterone or Testosterone data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Dec 2017. CN: Export: Single Preparation, Containing 1-testosterone or Testosterone data is updated monthly, averaging 0.000 USD th from Mar 2011 (Median) to Mar 2018, with 45 observations. The data reached an all-time high of 1,081.956 USD th in Oct 2015 and a record low of 0.000 USD th in Mar 2018. CN: Export: Single Preparation, Containing 1-testosterone or Testosterone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Mar 2011 - Mar 2018 |
View China's Export: Single Preparation, Containing 1-testosterone or Testosterone from Mar 2011 to Mar 2018 in the chart:
Export: Single Preparation, Containing Gonadotrophin
CN: Export: Single Preparation, Containing Gonadotrophin data was reported at 125.594 USD th in Mar 2018. This records an increase from the previous number of 0.000 USD th for Feb 2018. CN: Export: Single Preparation, Containing Gonadotrophin data is updated monthly, averaging 86.834 USD th from Jan 2011 (Median) to Mar 2018, with 84 observations. The data reached an all-time high of 994.556 USD th in Dec 2017 and a record low of 0.000 USD th in Feb 2018. CN: Export: Single Preparation, Containing Gonadotrophin data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 125.594 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Export: Single Preparation, Containing Gonadotrophin from Jan 2011 to Mar 2018 in the chart:
Import: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone)
CN: Import: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) data was reported at 0.000 USD th in Feb 2018. This stayed constant from the previous number of 0.000 USD th for Jan 2018. CN: Import: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) data is updated monthly, averaging 0.000 USD th from Mar 2012 (Median) to Feb 2018, with 12 observations. The data reached an all-time high of 0.000 USD th in Feb 2018 and a record low of 0.000 USD th in Feb 2018. CN: Import: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Feb 2018 | monthly | Mar 2012 - Feb 2018 |
View China's Import: 19-Noretiocholanlone (Including Oxabolone, Oxandrolone) from Mar 2012 to Feb 2018 in the chart:
Import: Androst-4-Allyl-3,17-Two Ketone
CN: Import: Androst-4-Allyl-3,17-Two Ketone data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Feb 2018. CN: Import: Androst-4-Allyl-3,17-Two Ketone data is updated monthly, averaging 1,497.149 USD th from Mar 2014 (Median) to Mar 2018, with 25 observations. The data reached an all-time high of 4,404.800 USD th in Apr 2014 and a record low of 0.000 USD th in Mar 2018. CN: Import: Androst-4-Allyl-3,17-Two Ketone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Mar 2014 - Mar 2018 |
View China's Import: Androst-4-Allyl-3,17-Two Ketone from Mar 2014 to Mar 2018 in the chart:
Import: Medicament Containing Corticosteroed Hormone
CN: Import: Medicament Containing Corticosteroed Hormone data was reported at 159,213.784 USD th in Mar 2018. This records an increase from the previous number of 68,446.517 USD th for Feb 2018. CN: Import: Medicament Containing Corticosteroed Hormone data is updated monthly, averaging 67,972.035 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 159,213.784 USD th in Mar 2018 and a record low of 19,538.858 USD th in Jan 2012. CN: Import: Medicament Containing Corticosteroed Hormone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 159,213.784 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Import: Medicament Containing Corticosteroed Hormone from Jan 2011 to Mar 2018 in the chart:
China Import: Mibolerone, Nandrolone, Norbolethone, Norclostebol
CN: Import: Mibolerone, Nandrolone, Norbolethone, Norclostebol data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Feb 2018. CN: Import: Mibolerone, Nandrolone, Norbolethone, Norclostebol data is updated monthly, averaging 0.000 USD th from Jan 2011 (Median) to Mar 2018, with 72 observations. The data reached an all-time high of 0.000 USD th in Mar 2018 and a record low of 0.000 USD th in Mar 2018. CN: Import: Mibolerone, Nandrolone, Norbolethone, Norclostebol data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Import: Mibolerone, Nandrolone, Norbolethone, Norclostebol from Jan 2011 to Mar 2018 in the chart:
Import: Other Medicament Containing Hormone or Product of Heading 2937
CN: Import: Other Medicament Containing Hormone or Product of Heading 2937 data was reported at 115,093.856 USD th in Mar 2018. This records an increase from the previous number of 33,076.380 USD th for Feb 2018. CN: Import: Other Medicament Containing Hormone or Product of Heading 2937 data is updated monthly, averaging 69,457.485 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 149,591.954 USD th in Jun 2017 and a record low of 24,823.721 USD th in Jan 2012. CN: Import: Other Medicament Containing Hormone or Product of Heading 2937 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 115,093.856 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Import: Other Medicament Containing Hormone or Product of Heading 2937 from Jan 2011 to Mar 2018 in the chart:
China Import: Other Polypeptide Hormone, their Derivative & Structural Analogue
CN: Import: Other Polypeptide Hormone, their Derivative & Structural Analogue data was reported at 3,343.418 USD th in Mar 2018. This records an increase from the previous number of 0.000 USD th for Feb 2018. CN: Import: Other Polypeptide Hormone, their Derivative & Structural Analogue data is updated monthly, averaging 25.221 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 3,964.335 USD th in Aug 2011 and a record low of 0.000 USD th in Feb 2018. CN: Import: Other Polypeptide Hormone, their Derivative & Structural Analogue data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 3,343.418 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Import: Other Polypeptide Hormone, their Derivative & Structural Analogue from Jan 2011 to Mar 2018 in the chart:
Import: Other Single Preparation Containing Human Insulin
CN: Import: Other Single Preparation Containing Human Insulin data was reported at 49,324.465 USD th in Mar 2018. This records an increase from the previous number of 25,456.588 USD th for Feb 2018. CN: Import: Other Single Preparation Containing Human Insulin data is updated monthly, averaging 27,025.587 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 58,019.645 USD th in Dec 2016 and a record low of 3,293.548 USD th in Apr 2011. CN: Import: Other Single Preparation Containing Human Insulin data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 49,324.465 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Import: Other Single Preparation Containing Human Insulin from Jan 2011 to Mar 2018 in the chart:
Import: Prostaglandin, Thromboxane & Leukotriene, their Derivative & Structural Analogue
CN: Import: Prostaglandin, Thromboxane & Leukotriene, their Derivative & Structural Analogue data was reported at 3,100.541 USD th in Oct 2024. This records an increase from the previous number of 370.618 USD th for Sep 2024. CN: Import: Prostaglandin, Thromboxane & Leukotriene, their Derivative & Structural Analogue data is updated monthly, averaging 342.259 USD th from Jan 2008 (Median) to Oct 2024, with 202 observations. The data reached an all-time high of 6,964.626 USD th in May 2023 and a record low of 0.000 USD th in Jul 2009. CN: Import: Prostaglandin, Thromboxane & Leukotriene, their Derivative & Structural Analogue data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Hormones and their Medicaments.
| Last | Frequency | Range |
|---|---|---|
| 3,100.541 Oct 2024 | monthly | Jan 2008 - Oct 2024 |